drugset / Trial / NCT02218021

A Study of the Abuse Liability Potential of Samidorphan in Healthy, Non-Dependent, Recreational Opioid Users

NCT02218021

Phase 1 Completed 59 enrolled Alkermes, Inc.
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate the abuse potential and safety of samidorphan in healthy, non-dependent, adult, recreational opioid users.

Timeline

Start
2014-08
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxycodone Other / unclassified
Subject Samidorphan Small molecule

Indications

No indication recorded.